MCU and atherosclerosis: This study confirmed that rosuvastatin can inhibit the Pyk2/MCU pathway during atherosclerosis process in ApoE–/– mice with high-fat diet and HUVECs exposed to H2O2, further promoting mitochondrial function by maintaining the MMP, blocking intracellular Ca2+ influx, and reducing ROS release.